Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.84)
# 398
Out of 5,051 analysts
349
Total ratings
45.3%
Success rate
27.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.29 | +597.67% | 15 | Oct 13, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $38 | $13.95 | +172.40% | 15 | Oct 12, 2026 | |
| VSTM Verastem | Reiterated: Buy | $18 | $7.45 | +141.61% | 13 | Oct 8, 2026 | |
| FHTX Foghorn Therapeutics | Reiterated: Buy | $13 → $5 | $1.85 | +170.27% | 10 | Oct 2, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $23 | $9.27 | +148.11% | 16 | Sep 30, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $14 | $3.56 | +293.26% | 4 | Sep 25, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $125 | $72.08 | +73.42% | 13 | Sep 21, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $11.01 | +354.13% | 13 | Sep 21, 2026 | |
| TARA Protara Therapeutics | Reiterated: Buy | $27 | $2.62 | +930.53% | 18 | Sep 21, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $35 | $4.78 | +632.22% | 20 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $70 | $40.52 | +72.75% | 33 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.58 | +127.53% | 8 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.63 | +145.40% | 15 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $1 | $0.2167 | +361.47% | 12 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $6.27 | +187.08% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $22 | $14.78 | +48.85% | 21 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.36 | +257.14% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $62.40 | +60.26% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.40 | +316.67% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $9.80 | +53.06% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.23 | +78.09% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $0.9911 | +303.59% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $4.24 | n/a | 11 | Nov 11, 2024 |
NovaBridge Biosciences
Oct 13, 2026
Reiterated: Buy
Price Target: $9
Current: $1.29
Upside: +597.67%
Syndax Pharmaceuticals
Oct 12, 2026
Reiterated: Buy
Price Target: $38
Current: $13.95
Upside: +172.40%
Verastem
Oct 8, 2026
Reiterated: Buy
Price Target: $18
Current: $7.45
Upside: +141.61%
Foghorn Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $1.85
Upside: +170.27%
Candel Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $23
Current: $9.27
Upside: +148.11%
Immuneering
Sep 25, 2026
Reiterated: Buy
Price Target: $14
Current: $3.56
Upside: +293.26%
Monopar Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $125
Current: $72.08
Upside: +73.42%
Sutro Biopharma
Sep 21, 2026
Reiterated: Buy
Price Target: $50
Current: $11.01
Upside: +354.13%
Protara Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $27
Current: $2.62
Upside: +930.53%
Corbus Pharmaceuticals Holdings
Sep 15, 2026
Reiterated: Buy
Price Target: $35
Current: $4.78
Upside: +632.22%
Sep 15, 2026
Reiterated: Buy
Price Target: $65 → $70
Current: $40.52
Upside: +72.75%
Sep 11, 2026
Reiterated: Buy
Price Target: $40
Current: $17.58
Upside: +127.53%
Sep 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
Sep 9, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.2167
Upside: +361.47%
Aug 12, 2026
Reiterated: Buy
Price Target: $24 → $18
Current: $6.27
Upside: +187.08%
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $14.78
Upside: +48.85%
Aug 10, 2026
Reiterated: Buy
Price Target: $12
Current: $3.36
Upside: +257.14%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $62.40
Upside: +60.26%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.40
Upside: +316.67%
Aug 4, 2026
Reiterated: Buy
Price Target: $15
Current: $9.80
Upside: +53.06%
Aug 4, 2026
Reiterated: Buy
Price Target: $20
Current: $11.23
Upside: +78.09%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $0.9911
Upside: +303.59%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $4.24
Upside: n/a